medicine zyprexa
Click on image below to visit
Eli Lilly is to settle more than 18 000 product liability claims against its lead product, the anti-psychotic drug (olanzapine) for schizophrenia and manic depression. The lawsuits mainly revolve around a warning linking the drug with diabetes not being adequately displayed in the package insert.
As with all neuroleptic drugs, olanzapine can cause tardive dyskinesia and rare, but life-threatening, neuroleptic malignant syndrome.
Other recognised side effects may include:
akathisia
amblyopia
dry mouth
dizziness
sedation
insomnia
orthostatic hypotension
weight gain (90% of users experience weight gain) (see below)
increased appetite
runny nose
low blood pressure
impaired judgment, thinking, and motor skills
impaired spatial orientation
impaired responses to senses
seizure
trouble swallowing
dental problems and discoloration of teeth
missed periods
problems with keeping body temperature regulated
apathy, lack of emotion